UPNEEQ® (oxymetazoline hydrochloride ophthalmic solution), 0.1% is a prescription eyedrop used to treat acquired blepharoptosis (low-lying lids) in adults.
Adults who suffer from ptosis have had the upper lid muscles weaken and stretch due to cataract surgery, wearing contact lenses, or who suffer from underlying medical conditions. False eyelash wearers may also experience ptosis early.
Acquired eyelid ptosis can be mild, moderate, or severe, and the sleepy-eyed effect becomes more apparent as the ptosis progresses.
UPNEEQ® stimulates the eyelid or Muller’s muscle to raise the upper eyelid. In as little as 15 minutes, UPNEEQ® gives you a bright-eyed and more youthful look. Clinical trials have proven the amount of upper eyelid life is 1 mm, and 84% of patients notice a visible improvement. Clinical studies also prove an improvement in vision.
UPNEEQ® application is one drop a day per eye. The medication comes in single-patient containers to ensure the proper dose is correctly administered.